News Update

Biopharma Receives PDUFA Goal Date for Nonopioid Pain Drug

News Update
  ()
The FDA deemed the firm's submission for analgesic approval complete. read more >

Seattle Genetics Shares Head Higher After Positive Earnings and ADCETRIS Sales Expansion

  ()
Seattle Genetics announced a 28.3% increase in net sales for its second quarter 2019 powered by ADCETRIS sales along with a promising pipeline. read more >
News Update

Biotech Incorporates Urologists' Feedback Into Device Design

News Update
  ()
This step moves the product further down the development track. read more >

Biotech Demonstrates Superiority of Polyp-Detecting Product

Research Report
  ()
The study results and their meaning are reviewed in an H.C. Wainwright & Co. report. read more >

Top Pick Status Given to Small-Cap with Pain Drug Candidate

Research Report
  ()
The primary reason for the rating—upcoming trial results—is discussed in an Echelon Wealth Partners report. read more >

Biopharma's Brain Cancer Therapeutic Compelling, Its Stock Undervalued

Research Report
  ()
A description of the asset and its potential are provided in a Dawson James report. read more >

Galapagos Agrees to $3.95 Billion, 10-Year Licensing Deal Plus $1.1 Billion Investment from Gilead

  ()
Galapagos announced that Gilead Sciences has agreed to pay $3.95 billion for a 10-year partnership and licensing deal and will invest an additional $1.1 billion in newly issued shares of the company. read more >

Illumina Shares Fall Sharply on Lower Revenue Guidance

  ()
Illumina Inc. shares traded down more than 15% as the company reported lower preliminary Q2/19 revenues and updated its annual revenue guidance. read more >

Technical Analyst: Medical Device Stock Looking Set to Reverse

Contributed Opinion
  ()
Technical analyst Clive Maund charts the stock of this company that has developed a device that uses a special light that visualizes cancer during minimally invasive surgery. read more >

CVS Declares Quarterly Dividend and Gets a Boost from Relaxed Rebate Policy

  ()
CVS Healthcare announced a $0.50/share quarterly dividend and got an added boost as news spreads regarding easing of federal restrictions on pharmacy rebate plans. read more >

Expert Investing Ideas

"The market for DRRX's POSIMIR could be substantial."

–Brian Marckx, Zacks Small-Cap Research


"DRRX's current valuation is an interesting buying opportunity."

–Francois Brisebois, Laidlaw & Company


"SPR is the number one cannabis stock to own today."

–Cynthia Berryman, Financial News Now


Get Our Streetwise Reports Life Sciences Report Newsletter Free and be the first to know!

A valid email address is required to subscribe
NASDAQ Biotech ARCA Pharmaceutical

Coverage Initiated on U.S. Biotech with a 'Potential Best-of-Breed Oncolytic Virus'

Research Report
  ()
The investment thesis on this immunotherapies developer is made in an H.C. Wainwright & Co. report. read more >

Biopharma Starts 'Key Catalyst Period,' H2/19, with Clinical Trial in New Indication

Research Report
  ()
A study description and expected data readouts this year are provided in a ROTH Capital Partners report. read more >
News Update

Physician Testing of EMR-Integrated, Medical Cannabis Evaluation Tool Completed

News Update
  ()
The two firms involved plan to have the offering fully rolled out by Q3/19. read more >

Sangamo and Pfizer Report Positive Results for Hemophilia A Study

  ()
Sangamo Therapeutics and partner Pfizer reported positive results for phase 1/2 Alta study for hemophilia A at the International Society on Thrombosis and Hemostasis Congress in Melbourne, Australia. read more >